Targeted radiotherapy of bone malignancies.
Jansen
David R
DR
Radiochemistry, Department of Applied Chemistry, Necsa (South African Nuclear Energy Corporation Ltd.), P.O. Box 582, Pretoria 0001, South Africa. david.jansen@necsa.co.za
Krijger
Gerard C
GC
Kolar
Zvonimir I
ZI
Zonnenberg
Bernard A
BA
Zeevaart
Jan Rijn
JR
D000818:Animals; D001859:Bone Neoplasms / Q000473:pathology / Q000532:radiotherapy* / Q000556:secondary; D016503:Drug Delivery Systems; D015195:Drug Design; D006801:Humans; D010146:Pain / Q000209:etiology / Q000532:radiotherapy*; D010166:Palliative Care / Q000379:methods; D011788:Quality of Life; D011829:Radiation Dosage; D019275:Radiopharmaceuticals / Q000008:administration & dosage*
D019275:Radiopharmaceuticals